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Gene expression is regulated by promoters, which initiate transcription, and enhancers, which control their
temporal and spatial activity. However, the discovery that mammalian enhancers also initiate transcription ques-
tions the inherent differences between enhancers and promoters. Here, we investigate the transcriptional properties
of enhancers during Drosophila embryogenesis using characterized developmental enhancers. We show that while
the timing of enhancer transcription is generally correlated with enhancer activity, the levels and directionality of
transcription are highly varied among active enhancers. To assess how this impacts function, we developed a dual
transgenic assay to simultaneously measure enhancer and promoter activities from a single element in the same
embryo. Extensive transgenic analysis revealed a relationship between the direction of endogenous transcription and
the ability to function as an enhancer or promoter in vivo, although enhancer RNA (eRNA) production and activity
are not always strictly coupled. Some enhancers (mainly bidirectional) can act as weak promoters, producing
overlapping spatio–temporal expression. Conversely, bidirectional promoters often act as strong enhancers, while
unidirectional promoters generally cannot. The balance between enhancer and promoter activity is generally
reflected in the levels and directionality of eRNA transcription and is likely an inherent sequence property of the
elements themselves.
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Transcription in higher eukaryotes is regulated by the in-
terplay of regulatory information encoded in promoters
(where gene transcription initiates) and more distal en-
hancers. Despite sharing some features such as transcrip-
tion factor (TF)-binding sites, promoters and enhancers
have historically been considered as two distinct classes
of regulatory elements. The term “promoter” implies
the ability to recruit RNA polymerase II (Pol II) and initi-
ate gene expression either at focused transcriptional start
sites (TSSs; often called narrow promoters) or through
more dispersed regions (broad promoters) (Lenhard et al.
2012; Roy and Singer 2015; Schor et al. 2017; Vo Ngoc
et al. 2017). In contrast, enhancers are defined by their
ability to activate transcription remotely using a promot-
er at another distal site and to function in an orientation-
independent manner. Naively, enhancers therefore were
not expected to have the necessary sequences for tran-
scription initiation themselves. However, transcription
has been observed at well-characterized enhancers (Tuan
et al. 1992) and more globally (Tuan et al. 1992; De Santa
et al. 2010; Kim et al. 2010; Lam et al. 2013). Moreover,
Pol II and general TFs can bind to enhancers (Koch et al.
2011), suggesting that they have some inherent promoter
activity.
Enhancer transcription and its product, enhancer RNA
(eRNA), have been extensively studied in mouse and hu-
man cells, where several common properties emerged.
Mammalian eRNAs are generally nonpolyadenlyated,
low in abundance, unspliced, and retained within the nu-
cleus (De Santa et al. 2010; Kim et al. 2010; Core et al.
2012; Andersson et al. 2014a,b). They are often bidirec-
tionally transcribed (Kim et al. 2010; Melgar et al. 2011;
Hah et al. 2013; Kaikkonen et al. 2013; Andersson et al.
2014a), although some unidirectional transcription has
also been reported (Ho et al. 2006; Kim et al. 2007; De
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Santa et al. 2010; Koch et al. 2011). InCaenorhabditis ele-
gans, putative enhancers (intergenic TF-bound regions)
have bidirectional eRNA transcription but form longer
transcripts in the direction of the closest downstream
gene (Chen et al. 2013). This resembles some intragenic
mammalian enhancers, which also transcribe long non-
coding RNA (lncRNA) transcripts in the direction of the
gene’s transcription (Kowalczyk et al. 2012). This suggests
that these long unidirectional eRNAs are a different class
from short bidirectional unstable eRNAs, or perhaps there
is a continuum of eRNA with different lengths and direc-
tionality in between. The ability to transcribe eRNA ap-
pears autonomous to the enhancer sequence itself, as
eRNA production occurs independently of the transcrip-
tion of the target gene, at least in the case of the α-globin
promoter (Vernimmen 2014). In keeping with this, many
transcribed enhancers have Initiator (INR)-like motifs
that are positioned at the point of eRNA transcription in
both vertebrates (Andersson et al. 2014a) and C. elegans
(Chen et al. 2013).
The functional role of eRNAs remains unclear (for re-
views, see Natoli and Andrau 2012; Lam et al. 2014).
Whether it is the process of enhancer transcription that
is important (Wilson et al. 1996; Cho et al. 1998; Kaikko-
nen et al. 2013) or the eRNA itself (Lam et al. 2013; Melo
et al. 2013; Li et al. 2014) may vary from one locus or con-
text to another. Alternatively, it may be a nonfunctional
consequence of the random engagement of Pol II to open
chromatin (Struhl 2007). Nevertheless, there is clear asso-
ciation between enhancer transcription and enhancer ac-
tivity, as observed at well-characterized enhancers (e.g.,
in the α-globin [Vernimmen et al. 2007] and β-globin
[Tuan et al. 1992; Plant et al. 2001] loci) and globally at pu-
tative enhancers following TF stimulation (as shown for
p53 [Melo et al. 2013], FoxA1 [Wang et al. 2011], and estro-
gen receptor [Hah et al. 2013]). Moreover, when stimulat-
ing gene expression, transcription of noncoding elements
(putative enhancers) often precedes that of the stimulus-
induced genes’ expression, as observed in mouse primary
neurons (Kim et al. 2010) and macrophages (Kaikkonen
et al. 2013). Consistent with this, the timing of Pol II en-
hancer occupancy is highly predictive of the timing of en-
hancer activity (Bonn et al. 2012a). This cumulative
evidence indicates a strong link between eRNA produc-
tion, enhancer activity, and gene expression.
This growing evidence indicates that enhancers have
some inherent promoter capacity, raising the question of
whether promoters reciprocally possess enhancer activi-
ty. A number of studies have measured the ability of dif-
ferent genomic elements to function as either enhancers
or promoters using massively parallel cell culture-based
reporter assays.Measuring promoter activity of thousands
of small DNA elements (Nguyen et al. 2016) or across the
entire human genome (van Arensbergen et al. 2017) sug-
gests that many enhancers (as well as repetitive elements)
can act as weak autonomous promoters, although at lev-
els ∼10-fold lower than that of annotated gene promoters.
Conversely, testing promoters for enhancer activity re-
vealed that ∼3% of human elements (Dao et al. 2017)
and 4.5% of Drosophila elements (Arnold et al. 2013)
spanning promoters have in vitro enhancer activity. Inter-
estingly, the percentage increased to 58.4% when testing
elements overlapping housekeeping promoters (Arnold
et al. 2013; Zabidi et al. 2015), indicating that these re-
gions have different inherent properties. Moreover, the
deletion of a number of promoter regions in mammals al-
tered the transcription of distal genes in cis, in keeping
with an enhancer-like function (Dao et al. 2017; Diao
et al. 2017).While indirect effects of the deletions on chro-
matin topology or other mechanisms cannot be excluded
in these studies, the accumulating evidence suggests
that some promoters have enhancer activity. Enhancer
and promoter activities thereby seem to be properties
that can co-occur in the same cis-regulatory element.
However, measurements of the ability of an element to
be activated by an enhancer, termed “enhancer respon-
siveness,” indicate that promoter and enhancer activities
are uncoupled in both their function and underlying se-
quence motifs (Arnold et al. 2017).
Although much of our understanding of how develop-
mental enhancers function has come from model
organisms, including Drosophila, enhancer transcription
remains largely unexplored in this long-standing model
organism. Here, we exploited thousands of characterized
developmental enhancers (Gallo et al. 2011; Bonn et al.
2012a; Kvon et al. 2014) and putative enhancers defined
by TF co-occupancy (Zinzen et al. 2009; Junion et al.
2012) available in Drosophila to characterize eRNA prop-
erties during embryogenesis using deeply sequenced PRO-
cap (a precision nuclear run-on sequencing variant) and
CAGE (cap analysis of gene expression) data. Our results
reveal that active developmental enhancers possess a
range of eRNA levels and directionality. We explored
the relationship between these properties and enhancer
and promoter function using a new in vivo assay, simulta-
neously assessing both activities for the same element
within the same embryo. This revealed that the ability
of enhancers to function as promoters in vivo is highly
correlated to both their level and directionality of eRNA
transcription. Intergenic enhancers transcribed predomi-
nantly bidirectionally can generally function as weak pro-
moters in both orientations. However, this was not the
case for themajority of elements (both enhancers and pro-
moters) with unidirectional transcription: The direction
of endogenous transcription was generally correlated to
the orientation in which the element can function as a
promoter in vivo. Testing gene promoters for enhancer
activity revealed that when bidirectionally transcribed,
promoters can function as enhancers in vivo, while unidi-
rectional promoters generally cannot. These proximal
bidirectional elements appear to function as both an en-
hancer and a promoter for the same gene, thereby regulat-
ing both their spatial pattern and levels of expression.
Taken together, our results indicate that there is a contin-
uum of cis-regulatory activity, with some elements acting
strictly as either an enhancer or a promoter, while others
function predominantly as an enhancer with weak pro-
moter activity, and yet others (for example, alternative
promoters) have both strong promoter and enhancer activ-
ity. This spectrum of activities is highly correlated with
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the directionality of their eRNA transcription, which like-
ly reflects the underlying sequence properties of the
element.
Results
Properties of Drosophila eRNA are similar to those
observed in vertebrates
Due to the compact nature of the Drosophila genome
(with an annotated TSS every ∼6.5 kb), many Drosophila
enhancers reside within genes (either protein coding or
noncoding) and in proximity to the 3′ ends of genes. Dro-
sophila enhancers therefore are often transcribed as a
consequence of the activity of RNAPol II running through
the enhancer due to gene transcription; e.g., lncRNAs
or transcriptional read-through at the 3′ ends of genes
(Supplemental Fig. S1). To specifically measure transcrip-
tion initiating at enhancers (eRNA) we used very deeply
sequenced CAGE data, providing quantitative informa-
tion on TSS usage at base-pair resolution (Shiraki et al.
2003; Carninci et al. 2006), and PRO-cap data (Mahat
et al. 2016), measuring 5′ ends of short nascent RNA
that are still transcriptionally engaged with Pol II, includ-
ing nascent unstable transcripts. The sensitivity and
accuracy of both techniques to detect eRNA has been
demonstrated in a number of studies in vertebrates
(Andersson et al. 2014a; Core et al. 2014; Arner et al.
2015). We performed strand-specific PRO-cap on tightly
staged embryos at two embryonic timewindows: 3–4 h af-
ter egg laying (AEL), corresponding mainly to blastoderm
embryos when the majority of cells is multipotent (∼66
million mapped reads) (Supplemental Table S1), and 6–8
h AEL, mainly stages 10–11, when the major lineages
within the mesoderm and neuronal primordia are speci-
fied (∼52 million mapped reads) (Supplemental Fig. S2;
Supplemental Table S2). This was complemented by our
previously published CAGE data (Schor et al. 2017), per-
formed on 81 wild-type inbred lines from the same popu-
lation at the same two stages of embryogenesis (Materials
andMethods). As differences in gene expression are higher
between developmental time points than between indi-
viduals at a given time point (Cannavò et al. 2017), we
combined CAGE reads from all samples at equivalent
time points, providing information on transcriptional ini-
tiation events at unprecedented depth (1045 million
mapped reads) at these two stages of embryogenesis (Sup-
plemental Tables S3, S4).
Mammalian eRNAs generally have low abundance, are
bidirectionally transcribed, and initiate within regions
enriched in the INR motif (Kim et al. 2010; Kaikkonen
et al. 2013; Andersson et al. 2014a). To assess these
properties in Drosophila, we first estimated the relative
abundance of eRNA using measurements of nascent tran-
scription in both species: The levels of PRO-cap signal in
Drosophila embryos (this study) was compared with
published GRO-cap (a global run-on sequencing variant)
signal in human K562 cells (Core et al. 2014) and PRO-
cap signal in Drosophila S2 cells (Kwak et al. 2013).
To make the analysis comparable between species, we
sampled the transcription data so that the median counts
at gene promoters (TSS-proximal regions) were similar
(Materials and Methods; Supplemental Fig. S3) and
estimated transcript abundance at intergenic DNase 1
hypersensitivity sites (DHSs) (John et al. 2011). This com-
parison indicates that the general distribution of enhancer
transcription is comparable between Drosophila and hu-
mans (Fig. 1A).
We next compared the directionality of Drosophila
eRNA. In contrast to Drosophila promoters, which are
generally directionally transcribed, transcription at puta-
tive enhancers in S2 cells appears more bidirectional
(Core et al. 2012). We reassessed this using our embryonic
PRO-cap data and calculated the orientation index (OI)
(Core et al. 2012) of intergenic regulatory elements (puta-
tive enhancers) in bothDrosophila and human cells (Sup-
plementalTable S5). TheOI represents the fractionof total
reads transcribed on the strand with the highest PRO-cap
signal (Core et al. 2012). To avoid confounding effects
from gene transcription, we divided DHS elements into
intergenic (located at least 0.5 and 1.5 kb away from gene
5′ and 3′ ends, respectively; putative enhancers), intragen-
ic, and promoters (overlapping annotated TSS). The intra-
genic and intergenic elements were further filtered to
remove unannotated promoters using genome-wide anno-
tation of lncRNAs (Young et al. 2012) and RAMPAGE-de-
finedTSSs (Batut et al. 2012). Transcription initiating from
Drosophila promoters, as seen by the cumulative distribu-
tions of theOI, is highly directional comparedwithhuman
promoters, being skewed toward one of the DNA strands
(Fig. 1B), an inherent characteristic of fly promoters
(Kutach and Kadonaga 2000; Ohler 2006; Core et al.
2012). In contrast, intergenic Drosophila elements (puta-
tive enhancers) are transcribed with no particular direc-
tionality preference, similar to what is observed in
mammals (Fig. 1B). We note that while this trend holds
true globally, intergenic elements have a continuum of
directionality, with some (putative) enhancers displaying
bidirectional transcription that is asymmetrically biased
to one strand or unidirectional transcription (44%of inter-
genic elements have an OI > 0.8). This property is also ob-
served in mammals (Ho et al. 2006; Kim et al. 2007; De
Santa et al. 2010; Koch et al. 2011) and is one that we ex-
plore in more detail below.
Drosophila eRNAs transcribed from intergenic DHSs
are also associated with INR motifs (Fig. 1C). We exam-
ined bidirectional (OI < 0.6) and unidirectional (OI > 0.8)
transcribed intergenic DHSs separately for INR motif en-
richment (using the position weight matrix [PWM] shown
in Fig. 1C). This revealed that the INRmotif is positional-
ly enriched at the maximal point of strand-specific eRNA
transcription (Fig. 1C). Interestingly, bidirectionally tran-
scribed elements have the INR motif enriched on both
strands, while unidirectionally transcribed elements are
preferentially enriched on the strand that is more tran-
scribed (Fig. 1C). Taken together, this suggests that the
presence (and quality) of one or more INR motifs dictates
the mode of enhancer transcription (either unimetrically,
bimetrically, or asymmetrically transcribed). In contrast
to the INR motif, we observed no enrichment of motifs
Mikhaylichenko et al.
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associated with promoter directionality in mammals
(such as the downstream U1 splice sites) or depletion of
upstream polyadenylation sites (PASs) (Almada et al.
2013) at putative enhancers (Supplemental Fig. S4), while
these motifs have the expected distribution at promoters
(Supplemental Fig. S4).
Taken together, these three lines of evidence—namely,
the similarity in eRNA levels, their directionality, and po-
sitional enrichment of the INR motif—indicate that the
general properties of enhancer transcription are conserved
between Drosophila and vertebrates, strongly suggesting
that they arise from a similar mechanism. Given that
eRNAs have also been observed in worms (Chen et al.
2013), they are likely a common feature of enhancers
across higher metazoa.
Linking enhancer transcription to enhancer activity
during embryogenesis
eRNA transcription is highly correlated with enhancer
activity and induced gene expression in vertebrates, as
seen in a number of studies in both mice and humans
(Plant et al. 2001; Vernimmen et al. 2007; Kim et al.
2010; Wang et al. 2011; Hah et al. 2013; Kaikkonen
et al. 2013; Melo et al. 2013). Given this, we next inves-
tigated the direct relationship between eRNA and en-
hancer activity during Drosophila embryogenesis,
making use of the thousands of characterized develop-
mental enhancers whose spatial and temporal activity
has been assessed in vivo in transgenic embryos (Gallo
et al. 2011; Bonn et al. 2012a; Kvon et al. 2014). Both
PRO-cap and CAGE signals were used as two indepen-
dent measures of eRNA expression. We compiled a uni-
fied set of embryonic enhancers (Materials and
Methods), which are either active or inactive during the
studied two time windows of embryogenesis. As many
of the characterized enhancer regions are quite large (2
kb or more), DHS peaks (Thomas et al. 2010) during em-
bryogenesis were used to refine the enhancer boundaries
and remove elements with multiple DHS peaks, which
likely span multiple enhancers (Materials and Methods).
We also excluded regions within 500 base pairs (bp) of a
TSS, both annotated and unannotated (using RAMPAGE
data [Batut et al. 2012] and putative lncRNA promoters
[Young et al. 2012]). This resulted in a high-stringency
set of 1037 embryonic enhancers, each with a single
DHS peak and characterized spatio–temporal activity,
of which 220 were intergenic (Supplemental Table S6).
In addition, we included 63 regions that do not function
as enhancers (at least within the tested context) at any
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Figure 1. General properties of eRNA are similar be-
tween Drosophila and vertebrates. (A) Histograms of
GRO-cap (human K562 cells [Core et al. 2014]) and
PRO-cap (Drosophila S2 cells [Kwak et al. 2013] andDro-
sophila embryos [6–8 h]) signal at intergenic DHS regions
located at least 0.5 and 1.5 kb away from gene 5′ and 3′
ends, respectively. Unannotated TSSs were removed in
Drosophila. (B) Cumulative distributions of transcrip-
tion orientation index (OI) values estimated (using sub-
sampled data from A) over intergenic and promoter
DHSs in human K562 cells (Core et al. 2014),Drosophila
S2 cells (Kwak et al. 2013), andDrosophila embryos (6–8
h). OI was estimated as the maximum PRO-cap signal
(>500 base pairs [bp] around enhancer center) on either
DNA strand divided by the sum of signal from both
strands, giving a range between 0.5 and 1 (Core et al.
2012). While Drosophila promoters (blue line in S2 cells
and embryos) are very directional, intergenic DHSs (yel-
low lines) have similar bidirectional transcription in
both flies and human. (C ) Levels of eRNA transcription
(PRO-cap; 6–8 h), using loess-smoothed summed reads
within intergenic DHSs (Supplemental Table S5) cen-
tered on the DHS signal maximum. (Top) Bidirectional
(OI≤ 0.6; n = 456) transcribed intergenic DHSs. (Bottom)
Unidirectional (OI≥ 0.8; n = 696) transcribed intergenic
DHSs (putative enhancers). Sense strand (red) is defined
as a strand with a higher transcription level. INR enrich-
ment (using the position weight matrix at the bottom
left) at the site of maximal transcription initiation in
the same regions calculated separately for the sense
(red) and antisense (blue) strands. Five-hundred bases
around the center are shown; central enrichment and sig-
nificance were estimated by CentriMo (Bailey and
Machanick 2012).
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stage of embryogenesis (Kvon et al. 2014), referred to as
nonenhancers (Supplemental Table S6).
Comparing the quantitative levels of eRNA signal with
enhancer activity revealed that active enhancers (ele-
ments with enhancer activity in transgenic embryos at
6–8 h of embryogenesis) have significantly higher levels
of PRO-cap and CAGE signal compared with inactive en-
hancers (enhancers that are inactive at 6–8 h of embryo-
genesis but active in transgenic embryos at earlier or
later time points) (Fig. 2A,B). Similarly, at early stages of
embryogenesis, enhancers that are active at 3–4 h have
significantly higher levels of eRNA compared with en-
hancers that are inactive at these stages but will become
active at later embryonic time points (Supplemental Fig.
S5A,B). Developmental enhancer transcription in Droso-
phila therefore is highly correlated with the timing of
the enhancer’s activity. To confirm that eRNA expression
also matches the specific tissue in which the enhancer is
active, we dissociated 6- to 8-h embryos and sorted meso-
dermal cells using FACS to >95% purity and performed
CAGE on the isolated RNA (Supplemental Fig. S2B; Sup-
plemental Table S7). The level of mesoderm-specific
eRNA transcription (quantitative CAGE signal) is signifi-
cantly higher at enhancers that are active in the meso-
derm at 6–8 h compared with enhancers that are
inactive in the mesoderm but active in other tissues at
these embryonic stages (Fig. 2C). eRNA levels therefore
are highly correlated with developmental enhancer activ-
ity both temporally and spatially in Drosophila, in keep-
ing with similar observations in vertebrate tissues and
cell culture models (Andersson et al. 2014a; Wu et al.
2014; Arner et al. 2015).
While this holds true generally, we noticed that within
a given tissue and time point, the levels of eRNA are high-
ly varied among different active enhancers. To investigate
this further, we ranked all intergenic non-TSS DHS
Figure 2. eRNA transcription is correlatedwith developmental enhancer activity. (A–C ) Levels of eRNA transcription centered onDHSs
within characterized developmental enhancers (both intergenic and intragenic) in an active or inactive state. (A,B) PRO-cap and CAGE
(Schor et al. 2017) signal from embryos at 6–8 h at enhancers that are active at 6–8 h in any embryonic tissue or inactive at 6–8 h but active
at other time points in any tissue. (C ) CAGE signal frommesodermal cells (CAGEmesoderm) at 6–8 h at enhancers active inmesoderm at
6–8 h or inactive inmesoderm at 6–8 h but active in other tissues at the same time. (D) Box plots show levels of eRNA transcripiton (log2,
PRO-cap) at 6–8 h in intergenic DHSs within active characterized enhancers (red), inactive enhancers at 6–8 h (green), and nonenhancer
regions (gray). P-values are from one-sided Wilcoxon rank sum test. (E) Heat map showing ranked eRNA signal (PRO-cap; 6–8 h) and cor-
responding DHS signal (6–8 h; log2 of the sum of reads per region) over all intergenic DHSs (n = 4562) (Supplemental Table S5). The posi-
tions of intergenic enhancers active (126) or inactive (42) at 6–8 h and nonenhancers (63) are shown. (F, top) Transgenic embryos showing in
situ hybridization against the lacZ reporter gene (green) and a mesodermal marker (Mef2; red). (Bottom) Genomic regions showing PRO-
cap, CAGE, andmesodermalCAGE (meso-CAGE) signal at 6–8 h on positive strand (red), negative strand (blue), andDNase (black) stage 11
(Thomas et al. 2010). The tested enhancer boundaries are indicated by the horizontal blue shading. TheBN31 enhancer has relatively high
levels of transcription (mainly on the negative strand) compared withmiR-1_miR-1.
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elements at 6–8 h (4562) by their level of PRO-cap signal
(Supplemental Table S5) and then visualized where active
enhancers (126), inactive enhancers (42), and nonen-
hancers (63) are located along this quantitative spectrum
(Fig. 2E). This revealed that active enhancers have a
wide range of eRNA expression, including some that in-
terestingly show no detectable levels of transcription
(Fig. 2D,E). Although this “absence of evidence” could
be a sensitivity issue, it suggests that not all active en-
hancers have eRNA. Certainly, not all active enhancers
have the same levels of eRNA. To explore this further,
we selected two enhancers with very different levels of
eRNA and assessed their activity in vivo by linking
them to the same minimal promoter and inserting them
into the same genomic location in a transgenic reporter
assay (Fig. 2F). While both enhancers drive reporter gene
expression in the mesoderm at stages 10–11 (6–8 h) to
comparable levels, the BN31 (Bonn et al. 2012a) enhancer
has much higher eRNA levels compared with the
miR1_miR1 (Biemar et al. 2005) enhancer (Fig. 2F). This
observed difference in eRNA production between the
two enhancers therefore is not due to differences in the
numbers of cells in which the enhancers are active; if any-
thing, themiR1_miR1 enhancer (with loweRNA levels) is
active in a larger fraction of cells (Fig. 2F). In linewith this,
some inactive enhancers also transcribe eRNA, as do, sur-
prisingly, some “nonenhancer” regions (Fig. 2E; Kvon
et al. 2014). The latter group has no detectable function
as developmental enhancers in vivo at any stage of em-
bryogenesis (Kvon et al. 2014) and yet is actively tran-
scribed and DNase-hypersensitive, indicating that it is
bound by TFs.
In summary, these results demonstrate a strong correla-
tion between eRNA and enhancer activity, a feature sim-
ilar to mammals. When transcription is initiating at an
enhancer, the enhancer is very likely to be active; howev-
er, the converse does not always hold true. Transcription
cannot be detected at all active enhancers, suggesting that
at least for this subset, eRNA is not mechanistically re-
quired for their activity. While enhancer transcription is
also highly correlated with enhancer activity in mam-
mals, we note that Andersson et al. (2014a) found that
20%–33% of nontranscribed regulatory regions can acti-
vate transcription in an in vitro enhancer assay, suggest-
ing that they may also function as enhancers without
eRNA transcription.
Highly transcribed developmental enhancers have weak
promoter activity in vivo
Transcribed enhancers have some promoter-like motifs,
including the INRmotif, leading to the proposal of a “uni-
fied architecture” between enhancer and promoter
sequences (Core et al. 2014; Andersson et al. 2015). How-
ever, promoters differ strongly from enhancers in their
ability to be activated by enhancers (enhancer responsive-
ness) (Arnold et al. 2017) and to regulate spatial activity.
While core promoters have ubiquitous activity, develop-
mental enhancers generally drive specific temporal and
spatial expression. We therefore asked whether enhancers
withdifferent transcriptional properties (such as transcrip-
tion orientation, RNA abundance, and stability) have dif-
ferent functional properties in an in vivo promoter assay.
The majority of studies investigating common func-
tional properties between promoters and enhancers
(Nguyen et al. 2016; Dao et al. 2017; Diao et al. 2017;
van Arensbergen et al. 2017) has used cell culture-based
approaches, relying on transient transfection that can
be performed at a large scale. However, these assays func-
tion outside of a normal chromatinized context, an im-
portant property known to affect both promoter
(transcriptional initiation) (Archer et al. 1992) and en-
hancer (Inoue et al. 2017) activity through various mech-
anisms (Jeong and Stein 1994; Hebbar and Archer 2008).
We therefore set out to assess the ability of enhancers
to act as promoters in vivo in transgenic embryos using
a stably integrated reporter that does not contain a core
promoter.
We first ranked enhancers–both in vivo characterized
(Gallo et al. 2011; Bonn et al. 2012a; Kvon et al. 2014)
and predicted (Zinzen et al. 2009)—by their levels of
eRNA based on their nascent PRO-cap signal (Fig. 3A;
Supplemental Table S8). We selected eight elements:
four with high (arbitrary cutoff >240 PRO-cap reads) and
four with low (at least four times lower; <60 PRO-cap
reads) levels of eRNA. Each element was inspectedmanu-
ally to confirm that no other source of transcription was
located in their proximity, which could confound the
eRNA signal (Fig. 3C). All eight elements were placed in
front of a LacZ reporter with and without a minimal
hsp70 promoter to examine their ability to function as
an enhancer or promoter, respectively (Fig. 3B; Supple-
mental Fig. S6). Five of these regions were shown previ-
ously to function as an enhancer in vivo (Lohmann
2003; Biemar et al. 2005; Bonn et al. 2012a). Here, the
cloned candidate regions were centered on the maximum
eRNA signal (median size 613 bp) (Supplemental Table
S9) and inserted in an orientation where the maximum
transcription occurred in the direction of the reporter
gene. The derived 16 constructs were stably integrated
into the same genomic location (51C landing site of the
J27 line) using the ϕC31 integrase system (Bischof et al.
2007) to minimize positional effects. Both enhancer and
promoter activities were assessed by fluorescent in situ
hybridization (FISH) with a probe directed against the
LacZ reporter gene.
As expected, seven out of eight elements displayed spe-
cific enhancer activity in vivo, the exception being a previ-
ously untested element. Importantly, promoter activity
was detected in four out of eight cases, three of which
have high levels (CRM3316 [Fig. 3B], BN5-lf-p, and BN5-
lf-n [Supplemental Fig. S6]) and one that has low levels
(rpr4s5 [Supplemental Fig. S6]) of endogenous eRNA.
This suggests a relationship between the level of eRNA
and an enhancer’s inherent capacity to act as a promoter
in vivo, although we note that the number of tested en-
hancers is low. In all four cases, the relative intensity of
promoter signalwasmuchweaker than thatof the enhanc-
er-driven expression, a feature also observed in mammali-
an cells (Nguyen et al. 2016; van Arensbergen et al. 2017).
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For three of the four enhancers, the spatial pattern of
their promoter activity partially overlapped that of the en-
hancers’ activity but was limited to a smaller fraction of
cells (e.g., BN5-lf-p) (Supplemental Fig. S6). Therefore,
when the element is functioning as both an enhancer
and a promoter, the TFs that bind to the enhancer are still
able to direct Pol II activity in a specific spatial pattern. For
the remaining enhancer (CRM3316) (Fig. 3B), the spatial
pattern of the promoter’s activity was different from
when the element was functioning as an enhancer (in
the presence of the hsp70 minimal promoter): While
CRM3316 drives enhancer activity in the mesoderm, it
regulates promoter activity in the central nervous system
(Fig. 3B). This suggests that this element is acting as a pro-
moter for another “external” enhancer, which is likely a
neuronal enhancer in the vicinity of the transgenic inte-
gration site (discussed further below).
In summary, these results demonstrate that intergenic
enhancers can act as weak promoters in vivo. While, in
three cases, the element acted as both an enhancer and
promoter, driving activity in overlapping patterns, in the
fourth case, the enhancer possibly functioned as an ectop-
ic promoter for an external enhancer. We note that not all
transcribed enhancers (∼50%) have detectable promoter
activity, and this seems to correlate with their levels of
eRNA production. In the transgenic assay, promoter ac-
tivity is measured by in situ hybridization against lacZ,
a long (4309 bp), stable, polyadenylated mRNA. There-
fore, what we are classifying based on RNA sequencing
(RNA-seq) methods as “high” and “low” eRNA likely re-
flects both eRNA stability and inherent promoter
strength. Enhancers that can act as promoters in vivo
may have stronger inherent promoter sequences (e.g.,
INRmotif) and/or other properties that contribute to tran-
script stability.
A dual transgenic assay to measure both enhancer
and promoter activity in vivo
The standard enhancer reporter constructs used for trans-
genic studies in both flies and mice place the tested en-
hancer upstream of a minimal promoter. This includes
thewidelyusedDrosophila pHPelican andpHStinger vec-
tors (Barolo et al. 2000) and the modified vector that we
used above (Fig. 3B; Supplemental Fig. S6). However,
with this arrangement, it is impossible to discriminate be-
tween an enhancer’s inherent promoter or enhancer activ-
ity, as transcription may originate from the minimal
promoter or the candidate region inserted directly up-
stream of it. To address this, we generated a new vector
that can simultaneouslyassess both enhancer andpromot-
er activity from the same element in the same embryo.
The dual enhancer–promoter activity vector contains a
multiple cloning site in betweenanupstreamGFP reporter
Figure 3. Highly transcribed enhancers can function as
promoters in vivo. (A) Ranked PRO-cap 6- to 8-h signal
(log2) at characterized and putative enhancers based on
mesodermal TF occupancy (Zinzen et al. 2009), both
intergenic and intragenic (n = 3492) (Supplemental Table
S8). Eight regions tested for enhancer and promoter activ-
ities in vivo are indicated with high (red) or low (black)
transcription. (B) Double in situ hybridization of trans-
genic embryos with probes directed against the lacZ re-
porter gene driven by the tested element (green) and
mesoderm marker gene Mef2 (red). (Top panel)
CRM3316 acts as an enhancer, driving expression in
the somatic (asterisk) and visceral (white arrow) muscle
and overlapping Mef2. Expression driven by CRM3316
in the promoter assay is localized to the brain (white ar-
rowhead). Embryos (stage 13) are ventrally oriented with
anterior to the left. (Bottom panel)CRM669 acts as an en-
hancer, driving expression in the head ectoderm (white
arrow), but has no detectable activity as a promoter. Em-
bryos (stage 14) are dorsally oriented with anterior to the
left. (C ) Genomic loci of CRM3316 and CRM669 show-
ing PRO-cap, CAGE, andmeso-CAGE (frommesodermal
cells sorted by FACS) signal at 6–8 h on both the positive
(red) and negative (blue) strands. DHSs at stage 11 (span-
ning 6–8 h) (from Thomas et al. 2010). Blue shading indi-
cates the boundaries of tested regions.
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(containing a minimal promoter) and a downstream LacZ
(with nominimal promoter) (Fig. 4B). If the regulatory ele-
ment can act as an enhancer, it should be able to regulate
GFP expression fromadistance,while, if it can act as a pro-
moter, it will regulate LacZ expression. To confirm that
changing the position of the regulatory element (relative
to the minimal promoter) does not affect its enhancer ac-
tivity, we first directly compared the activity of a charac-
terized enhancer (BN5-lf-p) (Bonn et al. 2012a) cloned
into the dual enhancer–promoter vector and a modified
pH Pelican vector, both of which were stably integrated
into the same genomic location (Supplemental Fig. S7).
As expected, placing the enhancer further away from the
target gene’s promoter (GFP) led to a reduction in the level
of gene expression (Fukaya et al. 2016). However, notably,
the spatio–temporal pattern of the enhancer’s activity in
the somaticmuscle is the same in both constructs (Supple-
mental Fig. S7). Importantly, by placing the enhancer
downstream from the reporter gene, the enhancer–pro-
moter dual vector can unequivocally distinguish between
enhancer and promoter activities.
Enhancer versus promoter function is reflected in the
orientation of eRNA transcription
Enhancers were originally defined as elements that
regulate transcription at variable distances from their tar-
get genes and in an orientation-independent manner
(Banerji et al. 1981; Moreau et al. 1981). In contrast, pro-
moters have directionality in their initiation (Almada
et al. 2013), especially in Drosophila (Fig. 1B; Core et al.
2012). Drosophila intergenic and intragenic enhancers
are transcribed both unidirectionally and bidirectionally
(Fig. 4A), with a wide range in between where transcrip-
tion is asymmetrically biased to one strand compared
with the other. In light of this, we next assessed whether
there is a relationship between the direction of endoge-
nous enhancer transcription and its ability to function
as a promoter in vivo. To do this, we changed the orienta-
tion of eRNA transcription by flipping the orientation of
the regulatory element with respect to the reporter gene.
Given our observation that enhancers with “high”
eRNA can generally function as promoters (Fig. 3; Supple-
mental Fig. S6), we focused on enhancers with relatively
high levels of eRNA (>22 CAGE counts in at least one ori-
entation) but differences in the directionality inwhich the
eRNA is transcribed.We selected 20DHS regions overlap-
ping in vivo validated or putative enhancers fromTF occu-
pancy (Zinzen et al. 2009) with a range of eRNA OIs:
bidirectional (OI < 0.6), unidirectional (OI > 0.8), and those
in between (0.6 <OI < 0.8), which are generally asymmet-
rically biased to transcription on one strand, representing
∼41% of all enhancers (Fig. 4A).
Of the 20 tested regions, 10 were intergenic DHSs (in-
cluding one enhancer that we tested in the standard up-
stream assay) (Fig. 3), which have a range of eRNA OIs.
We also included 10 gene promoters comprised of five al-
ternative TSSs (three with various degrees of bidirectional
transcription [OIs of 0.56, 0.73 and 0.76] and two unidirec-
tional [OIs of 1 and 0.98]) and five primary main TSSs as
more “extreme” examples of directional elements (OI
values between 0.95 and 1) (Fig. 5C). “Main TSSs” were
classified as the TSSs with the maximum CAGE signal
at 6–8 h, while the remaining were assigned as alternative
TSSs (using unambiguous TSS-to-gene assignments from
Batut et al. 2012; FlyBase). For each genomic element,
the region encompassing the DHS peak (mean size of
487 bp) (Supplemental Table S9) was cloned in both the
sense and antisense orientation, leading to 41 transgenic
lines, including an empty control line. While enhancer
orientation (relative to the reporter gene’s promoter) is
expected to have no effect on enhancer activity, to our
knowledge, the effect of orientation on promoter activity
(LacZ expression) has not been assessed in vivo.
All intergenic regions tested function as enhancers in
vivo, regulating GFP expression in specific tissues and
stages (Fig. 4C,D; Supplemental Fig. S8). In all 10 cases,
the enhancer functioned in both orientations, regulating
qualitatively similar spatio–temporal activity (Fig. 4C,D;
Supplemental Fig. S8). Notably, seven out of the 10 inter-
genic enhancers (including one previously tested in the
single activity assay [BN5-lf-p]) (Supplemental Fig. S7)
can also function as promoters in vivo, regulating weak
but spatially restricted LacZ expression. This suggests
that at least a fraction of Drosophila enhancers that initi-
ate transcription can function as weak promoters in vivo.
We note that as the dynamic range of transcription mea-
sured by deep RNA-seq is much higher than that detected
by in situ hybridization, wemay havemissed low levels of
promoter activity in our in vivo reporter assay and thereby
underestimated this function. In five out of seven cases,
the promoter activity at least partially recapitulates the
enhancer activity: CRM5130 (Fig. 4C), CRM4566 (Fig.
4D), BN5-lf-p (Supplemental Fig. S7), CRM1149, and
rpr4s4 (Supplemental Fig. S8). In the remaining two cases
(CRM1594 and CRM3105) (Supplemental Fig. S8), two
somatic and visceral muscle enhancers drive weak pro-
moter expression in the brain, mirroring the result ob-
served for CRM3316 inserted in the same location (Fig.
3B; Supplemental Fig. S8), suggesting that their promoter
activities might be controlled by an external enhancer. In-
terestingly, both CRM1594 and CRM3105 produced this
promoter pattern in an orientation-dependent manner
(Supplemental Fig. S8). Why only three of the 27 tested el-
ements (20 in the dual assay and eight in the single assay,
with one in common) were susceptible to this extrinsic
enhancer’s activity in the promoter assay is unclear. It
may reflect potential enhancer core promoter specificity,
as shown in other cases (Butler and Kadonaga 2001; Zabidi
et al. 2015). However, given this, we conclude that the spa-
tial promoter activity intrinsic to all of the enhancers test-
ed recapitulates all or a subset of the enhancer activity.
Eight of the 10 tested promoters (five out of five alterna-
tive TSSs and three out of five main TSSs) can function
as promoters in vivo, as expected (Fig. 5; Supplemental
Fig. S9). The majority of tested elements has ∼10-fold
higher endogenous transcription in one direction (the di-
rection of the gene’s expression) and is therefore highly
unidirectional. We used these elements and the 10 inter-
genic elements, which have a range of bidirectional and
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Figure 4. The direction of eRNA trancription is associatedwith the ability of an enhancer to function as a promoter. (A, left panel) eRNA
expression (Y-axis; log2 PRO-cap 6–8 h) and the transcription OI (X-axis) at intergenic (red; n = 253) and intragenic (yellow; n = 1751) en-
hancers and promoter regions (blue; n = 1163). Enhancers is a combined set of characterized (active at 6–8 h) and putative (bound by at least
one mesodermal TF at 6–8 h) enhancers (Supplemental Table S8; Zinzen et al. 2009). The OI was estimated as the maximum PRO-cap
signal (>500 bp around enhancer center) on either DNA strand divided by the sum of signal from both strands, giving a range between
0.5 and 1 (Core et al. 2012). (Right panel) The cumulative probability distributions (Y-axis) of OI values (X-axis) calculated for intergenic
(red) and intragenic (yellow) enhancer and promoter regions (blue), as in A. To remove outliers, only elements with >30 reads (intergenic,
intragenic, and TSS), corresponding to 0.25 quantile (horizontal dashed line in the left panel), are plotted. n = 3167. Intergenic and intra-
genic enhancers show a bidirectional transcriptional pattern, while promoter regions aremore unidirectionally transcribed. (B) Schematic
of the dual-reporter vector used tomeasure enhancer (green) and promoter (magenta) activities simultaneously in the same embryos at the
same genomic location. (P) hsp70minimal promoter; (pA) polyadenylation signal; (element) putative regulatory element inserted into a
multiple cloning site. (C,D, left) Double in situ hybridization against gfp driven by theminimal promoter under the control of the inserted
element (enhancer activity; green) and the lacZ reporter driven by the inserted element (promoter activity; magenta). (Top) CRM5130
(Zinzen et al. 2009) drives highly overlapping enhancer (white arrow) and promoter (white arrowhead) expression in oenocytes and somatic
muscle in both sense and antisense orientations. Embryos (stage 11) are laterally oriented with anterior to the left. (Bottom) CRM4566
(Zinzen et al. 2009) has enhancer activity (green) in the hindgut and head ectoderm (white arrow) and acts as promoter (magenta) in
the head ectoderm (white arrowhead) in both orientations. Embryos (stage 13) are laterally oriented with anterior to the left. OIs of endog-
enous transcription: 0.58 bidirectional and 0.96 unidirecitional. (Right) Genomic loci of CRM5130 and CRM4566, showing PRO-cap,
CAGE, and meso-CAGE (from FACS-sorted mesodermal cells) signal at 6–8 h on both the positive (red) and negative (blue) strands.
DHSs at stage 11 (spanning 6–8 h) (from Thomas et al. 2010). Blue shading indicates the boundaries of tested regions.
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unidirectional transcription, to determine whether the
orientation of the endogenous eRNA’s transcription is
predictive of promoter activity. Assessing promoter activ-
ity of each element when inserted in both orientations re-
vealed a strong association between the direction of its
endogenous transcription and the element’s ability to
Figure 5. Gene promoters can act as developmental enhancers. (A,B) Double in situ hybridization against gfp driven by theminimal pro-
moter under the control of the inserted element (enhancer activity; green) and the lacZ reporter driven by the inserted element (promoter
activity; magenta). (A, left) VT42494 (Kvon et al. 2014) drives overlapping enhancer (green) and promoter (magenta) expression in the pe-
ripheral nervous system and embryonic brain (white arrows, arrowheads) in sense and antisense orientations. Embryos are laterally (stage
11) or ventrally (stage 13) orientedwith anterior to the left. (B, left) TheTwist_440 bp_promoter element has overlapping enhancer (green)
and promoter (magenta) activity in the presumptivemesoderm (arrows) in the sense (plus) orientation. The asterisk indicates the cephalic
furrow. No activity was detected in the other orientation for either the enhancer or the promoter. Embryos are laterally (stage 6 or 7) ori-
ented with anterior to the left. (A,B, right) Genomic loci of VT42494 and Twist_440 bp_promoter showing PRO-cap, CAGE, and meso-
CAGE (fromFACS-sortedmesodermal cells) signal at 6–8 h on both the positive (red) and negative (blue) strands. DHSs at stage 11 (spaning
6–8 h) (from Thomas et al. 2010). Blue shading indicates the boundaries of tested regions. (C ) Summary of the activity of all of the tested
elements in the dual transgenic assay. (Orientation) Plus or minus DNA strand; (∗) strand with higher endogenous transcription; (enhanc-
er) tissues where enhancer (gfp) activity was detected; (promoter) tissues where promoter (lacZ) activity was detected; (CNS) central ner-
vous system; (SM) somatic muscle; (MA)midgut anlage; (HE) head ectoderm; (PNS) peripheral nervous system; (VNC) ventral nerve cord;
(HMS) head maxillary segment; (VM) visceral muscle.
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function as a promoter in the in vivo assay. Of the 15 ele-
ments that function as promoters, eight had detectable
promoter activity in both orientations and corresponded
to elements that were endogenously bidirectional yet of-
ten asymmetrically transcribed (with variable OIs <0.8,
with two exceptions that have largely unidirectional tran-
scription: CRM4566 [OI = 0.96] and BN5-lf-p [OI = 0.89]).
In the case of BN5-lf-p, the promoter activity appears
stronger in the orientation of endogenous transcription
(Supplemental Fig. S7), although we note that the in situ
hybridizations are not strictly quantitative.
In contrast, seven elements could function only as a
promoter in one orientation, and, in all cases, this corre-
sponds to the direction in which the bulk of their endo-
genous eRNA is transcribed (Twist_440bp_promoter
[Fig. 5B], CRM1594, CRM3105 [Supplemental Fig. S8],
VT32050, VT27684, ttk, and VT1617 [Supplemental Fig.
S9]). Five of these overlap gene promoters that are strongly
unidirectionally transcribed, either main or alternative,
where the direction of the endogenous transcription is
clearly linked to the orientation in which it can function
as a promoter.
An overview of all of the elements’ activity and direc-
tionality (OI) is shown in Figure 5C. To summarize, the
ability of enhancers to initiate transcription in a chromati-
nized context appears relatively common. Our results
demonstrate that endogenous promoter and enhancer ac-
tivities can coexist within the same element to regulate
similar spatio–temporal activity during embryonic devel-
opment and suggest a relationship between the direction
of endogenous transcription and the orientation in which
the element can function as a promoter in vivo. The only
three exceptions (out of 15) are intergenic enhancers that
have either unidirectional transcription but act as a pro-
moter in both orientations (CRM4566 [Fig. 4D] and
BN5-if-p [Supplemental Fig. S7B]) or bidirectional (al-
though asymmetric; OI = 0.68) transcription that can
only function as a weak promoter in one orientation
(CRM1594) (Supplemental Fig. S8).
Alternative gene promoters can function as
developmental enhancers in vivo
A number of recent studies using large-scale cell culture
assays indicate that a fraction of promoters can act as en-
hancers (Arnold et al. 2013; Zabidi et al. 2015; Nguyen
et al. 2016; Dao et al. 2017; Diao et al. 2017). Here, we in-
vestigated whether this also holds true in a chromatinized
background during embryonic development. Out of the 10
gene promoter regions tested above (five main TSSs and
five alternative TSSs), eight overlapped a 2-kb region
that was reported previously to have enhancer activity,
and two (VT2049 and VT1617) were reported to have no
enhancer activity (Kvon et al. 2014) and therefore served
as negative controls. Previously, these 2-kb fragments
were placed upstream of a minimal promoter and reporter
(Kvon et al. 2014), as in standard enhancer transgenic as-
says. Here we cloned ∼400-bp single DHS regions encom-
passing the promoter, placed them in the dual enhancer–
promoter vector, and assessed the ability of these promot-
er regions to also function as developmental enhancers.
In five out of 10 cases, the tested promoter region can
function as a developmental enhancer in vivo. Interesting-
ly, four of these five regions (VT4241, VT42494, VT62448,
and VT1617) are alternative TSSs; in all four cases, the el-
ements functioned as both a promoter and an enhancer,
giving largely overlapping spatial patterns of activity
(Fig. 5A; Supplemental Fig. S9). In three cases, both pro-
moter and enhancer activities occurred in both orienta-
tions, in keeping with the bidirectional transcription of
these elements (although asymmetric: OI values at 6–8
h for VT4241, VT42494, and VT62448 were 0.7, 0.72,
and 0.78, respectively) (Fig. 5A, summarized in C; Supple-
mental Fig. S9). In contrast, the fourth region overlapping
an alternative TSS, VT1617, has orientation-dependent
activity and unidirectional transcription. This element
does not have enhancer activity when tested in one orien-
tation (Supplemental Fig. S9B), as observed previously
(Kvon et al. 2014). However, it does have enhancer activity
in the head at early stages of embryogenesis in the other
orientation in addition to orientation-dependent promot-
er activity (Supplemental Fig. S9B). This region has very
strong unidirectional transcription (>4500-fold higher on
the antisense strand) (Supplemental Table S10), in keep-
ing with its directional ability to function as a promoter.
However, this orientation dependence for the enhancer
activity is surprising. The enhancer and promoter spatial
patterns driven by this element are very similar, although,
intriguingly, the two activities were observed in the oppo-
site orientations.
Interestingly, none of the main TSSs possesses enhanc-
er activity, with the exception of the twist gene (Fig. 5B,C;
Supplemental Fig. S9). The tested region contains a
single DHS that spans the gene’s main promoter and a
characterized enhancer—theTwist promoter-proximal el-
ement (Twist_440 bp_promoter)—that is located in very
close proximity to the main twist TSS (Jiang et al. 1991).
This element functions as an enhancer, as reported previ-
ously, but, surprisingly, our results indicate that it does so
in only one orientation (Fig. 5B, plus): when positioned
toward the lacZ gene in the same orientation as its unidi-
rectional transcription toward the endogenous twist gene
(Fig. 5B, plus strand). Moreover, the spatial activity of this
element when functioning as a promoter is broader than
its spatial enhancer activity, being active also in the ce-
phalic furrow (Fig. 5B, asterisk). In the other orientation,
where its unidirectional transcription extends antisense
toward gfp, the element had no detectable enhancer activ-
ity (i.e., sense gfp transcription). This orientation-depen-
dent enhancer activity may be due to transcriptional
interference from antisense gfp transcription, although
we note that there was no detectable antisense gfp tran-
scription by in situ hybridization (data not shown).
Taken together, these results indicate that some ele-
ments, either TSS-overlapping or TSS-proximal, can func-
tion as both a promoter and an enhancer (summarized in
Fig. 5C). This feature seems to be conserved in vertebrates
(Dao et al. 2017). In our case, the enhancer activity over-
laps the spatial expression of the associated gene,
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suggesting that the element is enhancing the expression of
the same gene in which it acts as a promoter. Our results
indicate a strong correlation between the direction of en-
dogenous promoter transcription and the ability of the
element to function as an orientation-independent
enhancer. Strictly unidirectional promoters had orienta-
tion-dependent enhancer activity, while only bidirection-
ally transcribed promoters (OI < 0.8) had orientation-
independent enhancer activity.
Discussion
Through the integration of information on transcription
initiation in the noncoding genome (using deeply se-
quenced CAGE and PRO-cap) with that of developmental
enhancer activity (using hundreds of in vivo characterized
embryonic enhancers), we assessed the general properties
ofDrosophila eRNA. Our results indicate that the general
features of eRNA are highly conserved from flies to hu-
mans, including the level and orientation of eRNA tran-
scription and the relative positioning of the INR motif.
During the course of this study, we generated 56 transgen-
ic lines to functionally assess regulatory elements with
different eRNAproperties for both enhancer and promoter
activity. Our results uncovered a number of intriguing fea-
tures suggesting that there is a continuumof enhancer and
promoter functions matching the continuum of endoge-
nous transcription.
eRNA levels generally correlate with enhancer activity
Comparing endogenous enhancer transcription with en-
dogenous enhancer activity in transgenic embryos re-
vealed a very strong global correlation between both the
timing (developmental stage) and place (tissue) of enhanc-
er activity. This is consistent with similar global compar-
isons in cell culture models and suggests a mechanistic
link to TF occupancy or some other property of enhancer
function. However, we also observed that active enhanc-
ers have a wide range of eRNA levels, with many active
enhancers having very low or undetectable eRNA at the
stages when the enhancer is active. Similarly low levels
of eRNAmay also occur in other species; 35% of putative
C. elegans enhancers do not overlap transcription initia-
tion clusters (TICs) (Chen et al. 2013), while 60% of inter-
genic putative mouse enhancers do not contain eRNA, as
reported in one study (Kim et al. 2010). While these per-
centages may be overestimated due to the inclusion of el-
ements that are not enhancers, nearly a third (20%–33%)
of nontranscribed regulatory regions demonstrated en-
hancer activity in a luciferase assay (Andersson et al.
2014a). In the context of our study, all elements were con-
firmed embryonic enhancers, and we carefully matched
the stage of enhancer activity to the stage of eRNA detec-
tion. Active embryonic enhancers therefore are tran-
scribed in a broad range, with the highly transcribing
enhancers producing several orders of magnitude more
transcripts than those with the weakest transcription,
suggesting that eRNA production and enhancer activa-
tion can be uncoupled (at least for a subset of enhancers).
For enhancers with very weak transcription, eRNAs are
likely to be present only sporadically or in a minority of
cells, suggesting that their continued presence is unlikely
to be essential for these enhancers’ function, although the
act of transcription might be.
Intergenic embryonic enhancers can function as weak
promoters
The presence of Pol II and the basal transcriptional ma-
chinery at enhancers (Koch et al. 2011) and their ability
to transcribe eRNAs question whether there is an inher-
ent difference between an enhancer and a promoter,
with some proposing a unified architecture between the
two (Andersson et al. 2015). To disentangle both activi-
ties, we developed a new dual transgenic assay that can
measure enhancer and promoter activity at the same ge-
nomic location in the same embryos such that the timing
as well as tissue specificity of both activities can be
directly compared. Transgenic assays have the advantage
of being able to measure regulatory activity at the endog-
enous levels of TFs andwithin a consistent chromatinized
context—two properties that have amajor impact on both
enhancer and promoter activity (Archer et al. 1992; Jeong
and Stein 1994; Hebbar and Archer 2008; Inoue et al.
2017). The readout (in situ hybridization) provides both
spatial and temporal information at single-cell resolution,
although it is difficult to derive quantitative information
on activity—a clear disadvantage compared with in vitro
reporter assays.
We tested 27 regulatory elements (20 in both orienta-
tions) from different genomic locations and with different
transcriptional properties for both enhancer and promoter
activity. Our results indicate that highly transcribed
developmental enhancers can function asweak promoters
in vivo. The spatial pattern of promoter activity was gen-
erally a subset of the tissues inwhich the enhancerwas ac-
tive, indicating that both activities can occur in the same
cells from the same element. This promoter function de-
pended largely on the orientation in which the element
was inserted, matching the direction of enhancer tran-
scription in its endogenous location: Bidirectional ele-
ments (both enhancers and promoters) can generally
function as promoters in both orientations, while unidi-
rectional elements have orientation-dependent activity
(Fig. 5C). This indicates that promoter activity has intrin-
sic directionality and suggests the presence of directional
sequence motifs within enhancer elements. In keeping
with this, bidirectional mammalian promoter regions
contain separate motifs that promote transcription in ei-
ther direction (Core et al. 2014; Duttke et al. 2015); our re-
sults point to a similar sequence-based determinant of
enhancer directionality in Drosophila, supported by the
presence of potential “pairs” of INRmotifs within bidirec-
tional enhancers at the two points of maximal divergent
transcription (Fig. 1C). Intragenic enhancers have been
shown previously to act as alternative promoters, regulat-
ing unidirectional transcription in the direction of the
host gene’s expression to produce lncRNAs that are
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abundant, stable (polyadenylated), and spliced (Kowalc-
zyk et al. 2012). In the case of the intergenic enhancers
studied here, we have no evidence that they produce sta-
ble long transcripts. Standard strand-specific poly(A)+
RNA-seq did not detect any RNA at the vast majority of
these enhancers, suggesting that Pol II elongation is fun-
damentally different at intergenic versus intragenic
enhancers.
A subset of promoters can function as developmental
enhancers
Recent high-throughput studies indicate that the same se-
quences can function as both promoters and enhancers in
vitro, although gene promoters generated more promoter
activity compared with distal elements (Nguyen et al.
2016; van Arensbergen et al. 2017). While our results
also show that the same sequences can harbor both activ-
ities, we uncovered some key differences. Tested ele-
ments that overlap a gene’s main promoter, while
acting as strong promoters both endogenously and in
the promoter assay, do not possess enhancer activity (at
least for four of the five elements examined). In contrast,
some alternative gene promoters have an intriguing dual
functionality, being able to act with seemingly equal
strength as strong enhancers and promoters at the same
stage in the same tissues. Using luciferase assays, Li
et al. (2012) found that strong and weak promoters have
different enhancer activities with an inverse relationship
between the two functions. Here, in the context of embry-
onic development, our results generally agree with this:
Strong promoters (the main genes’ promoters) generally
have no detectable enhancer activity, while “strong”
(highly active) intergenic enhancers have weak (or not
detectable) promoter activity (at least for the ones that
we tested). This indicates that developmental enhancers
and gene promoters generally have different intrinsic
properties.
However, we also found interesting intermediate cases
between the two, which suggests a relationship between
the directionality of eRNA transcription and the ability
to function as an enhancer or promoter in vivo. When bi-
directionally transcribed, alternative gene promoters can
function as both strong promoters and enhancers in vivo
in both orientations (Fig. 5A,C). In contrast, when unidi-
rectionally transcribed, the element can generally func-
tion only as a promoter (and, in a few cases, as an
enhancer) in an orientation-dependent manner matching
its direction of transcription. One interesting example of
the latter is an ∼400-bp DHS element that overlaps the
promoter of the twist gene and is transcribed in a unidirec-
tionalmanner. We show that this element can function as
both a promoter and an enhancer but, interestingly, can
perform both functions in only one orientation and is in-
active in the other (Fig. 5B). These results suggest that
some enhancers may have evolved to drive proximal ori-
entation-dependent activation, possessing strong intrin-
sic promoter potential but lacking the ability to act
more distally in an orientation-independent manner. To
summarize, bidirectional cis-regulatory elements (either
enhancers or promoters) can often function as both en-
hancers and promoters (although to different degrees) in
an orientation-independentmanner. In contrast, unidirec-
tional elements generally function only in the orientation
in which they are transcribed.
Taken together, our results suggest a continuum of
functions that mirrors the continuum of eRNA direction-
ality and levels of transcription at cis-regulatory elements
(Fig. 6). This spans from gene promoters that have high
levels of unidirectional transcription and functionmainly
as orientation-dependent promoters (with little or no en-
hancer function) to elements with bidirectional (high lev-
el) transcription giving both promoter and enhancer
orientation-independent activity (alternative promoters)
to more distal elements with low levels of asymmetric
or bidirectional transcription, which function mainly as
Alternative promoter Distal enhancerMain promoter
Pol II
INR
H3K4me3
H3K4me1
TFs
RNA
Promoter activity
unidirectional           bidirectional Enhancer activity
unidirectional            bidirectional
Figure 6. A continuum of eRNA directionality and levels reflects cis-regualtory function. Schematic representation of gene promoters,
alternative gene promoters, and enhancers showing the heterogeneity of transcription directionality (arrowhead orientation), abundance
(arrow height), and stability (arrow thickness) across regulatory elements. Going from left (strict promoters) to right (strict enhancers), the
levels and orientation of transcription vary, as do the functional properties of the cis-regulatory elelments, going from highly directional
promoters to nondirectional enhancers, with intermediate combinations with dual functionality in between.
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enhancers, with a subset having weak orientation-inde-
pendent promoter activity.
How has dual enhancer and promoter activity evolved?
Bidirectionality has been suggested to be the ground state
of transcription (Jin et al. 2017), and enhancer transcrip-
tion may reflect this, serving as a source of evolutionary
novelty. The finding that some TF-binding sites may pos-
sess the ability to initiate transcription (Nguyen et al.
2016) suggests that selection for enhancer activity could
allow promoter activity to arise as a by-product. If the
presence of low-level promoter activity either as a conse-
quence of selection for enhancer activity or simply due to
the relative nonspecificity of the transcriptional machin-
ery is common in enhancer elements, then eRNA could
be exploited by evolution for other purposes in transcrip-
tional regulation, including coactivator activity (e.g., acti-
vation of CBP [Bose et al. 2017] or TF trapping at
enhancers [Sigova et al. 2015]). Alternatively, transcribed
enhancers may have evolved from promoters, where a
promoter was duplicated and became separated from its
target gene over evolutionary time. Gradually, the se-
quence features leading to strong promoter activity would
become more degenerate, while the element may gain
more TF-binding sites. Although there is currently no ev-
idence of this, it would fit with the promoter and enhancer
activity that we observed and with the fact that some spe-
cies do not have distal enhancers but rather regulate gene
expression by TF binding very close to the promoter.
Although very speculative, alternative promoters may
represent an intermediate state (from an evolutionary per-
spective) between promoters and enhancers. A previous
study proposed that developmental enhancers evolve
from inducible-type promoters (Arenas-Mena 2017). Of
the elements that we tested, main gene promoters appear
to have evolved to drive proximal orientation-dependent
activation, possessing strong intrinsic promoter potential.
At the other extreme, distal enhancers possess weak pro-
moter potential but seem to have specialized toward a dis-
tal orientation-independent mode of action—a function
achieved, presumably, through acquiring binding sites
for a set of factors distinct from promoters. Distal enhanc-
ers themselves represent a heterogeneous population of
elements with variable transcriptional properties. The co-
existence of the two functions opens many questions:
How can the same regulatory element facilitate enhancer
and promoter function? Can one function be perturbed in-
dependently of the other? A preliminary answer to the lat-
ter is suggested here: Enhancer functionwas unaffected by
changing orientation, while some promoter activity was
lost, suggesting separate directional sequence determi-
nants for these promoters’ activity.
Materials and methods
Nuclei from unfixed frozen wild-type embryos (0.3–0.5 g) were
extracted, and PRO-cap was performed according to Kwak et al.
(2013) with minor modifications. To obtain mesoderm-specific
CAGE libraries, mesodermal cells were FACS-purified from un-
fixed 6- to 8-h staged embryos expressing an EGFP under the con-
trol of an early mesodermal enhancer from the twist gene (Bonn
et al. 2012b), and CAGE libraries were prepared as described in
Schor et al. (2017). Biological replicates for both PRO-cap and
CAGE came from independent embryo collections and RNA iso-
lations. Samples were multiplexed and sequenced by an Illumina
HiSeq 2000 sequencer (50-bp single-end reads). A detailed descrip-
tion of all of the data analysis is in the Supplemental Material.
For transgenic analysis, genomic regions tested in either the
single readout vector or the dual enhancer–promoter assay are
listed in Supplemental Table S9. All constructs were integrated
at chromosomal position ZH-51C using the J27 landing site (Bis-
chof et al. 2007). Homozygous embryos were formaldehyde-fixed
and used for double fluorescent in situ hybridization using anti-
sense probes against lacZ and Mef2 (Fig. 3; Supplemental Fig.
S6) or lacZ and gfp (Figs. 4, 5; Supplemental Fig. S7–S9). All imag-
es were taken with a Zeiss LSM 780 confocal microscope.
All raw sequencing data have been submitted to the European
Molecular Biology Laboratory-European Bioinformatics Institute
(EMBL-EBI) ArrayExpress database under accession numbers E-
MTAB-6154 (PRO-cap; 3–4 and 6–8 h) and E-MTAB-6159
(meso-CAGE; 6–8 h). Processed files for visualization are avail-
able at http://furlonglab.embl.de/data.
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